Detalhe da pesquisa
1.
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.
N Engl J Med
; 383(21): 2007-2017, 2020 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33207093
2.
Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis.
Rheumatology (Oxford)
; 60(10): 4495-4507, 2021 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493312
3.
Immunogenicity of golimumab and its clinical relevance in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Rheumatology (Oxford)
; 58(3): 441-446, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30412238
4.
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.
Ann Rheum Dis
; 77(1): 21-29, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28507219
5.
Clinical efficacy, radiographic and safety findings through 5â years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study).
Ann Rheum Dis
; 73(9): 1689-94, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24748630
6.
Pharmacokinetics and pharmacodynamics across infusion rates of intravenously administered nipocalimab: results of a phase 1, placebo-controlled study.
Front Neurosci
; 18: 1302714, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38362023
7.
Population Pharmacokinetics and Exposure-Response Modeling Analyses of Golimumab in Children and Young Adults With Recently Diagnosed Type 1 Diabetes.
J Clin Pharmacol
; 63(6): 721-731, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854991
8.
Development of Therapeutic Proteins for a New Subcutaneous Route of Administration After the Establishment of Intravenous Dosages: A Systematic Review.
Clin Pharmacol Ther
; 113(5): 1011-1029, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516352
9.
A Phase 1 First-in-Human Pharmacokinetic and Pharmacodynamic Study of JNJ-64264681, a Covalent Inhibitor of Bruton's Tyrosine Kinase.
Clin Pharmacol Drug Dev
; 12(6): 611-624, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37125450
10.
Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design.
Arthritis Rheumatol
; 75(10): 1856-1866, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067688
11.
Population Pharmacokinetic and Exposure-Response Model Simulations: Predicted Exposure and Efficacy for Maintenance Doses of Intravenous Golimumab Every 6 or 8 Weeks in Patients With Moderately to Severely Active Rheumatoid Arthritis.
Clin Ther
; 44(3): 457-464.e2, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35183373
12.
Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Arthritis Res Ther
; 24(1): 73, 2022 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313978
13.
Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapolation of Data from Studies in Adults and Adjacent Pediatric Populations.
Paediatr Drugs
; 24(6): 699-714, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171515
14.
Efficacy and Safety of Intravenous Golimumab Through One Year in Patients With Active Psoriatic Arthritis.
Arthritis Care Res (Hoboken)
; 72(6): 806-813, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30980514
15.
Immunogenicity of Golimumab and its Clinical Relevance in Patients With Ulcerative Colitis.
Inflamm Bowel Dis
; 25(9): 1532-1540, 2019 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30753466
16.
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study.
J Rheumatol
; 46(10): 1277-1283, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30824635
17.
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.
Arthritis Rheumatol
; 71(2): 258-270, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30225992
18.
Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study.
J Rheumatol
; 45(3): 341-348, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247154
19.
Effect of the rate of niacin administration on the plasma and urine pharmacokinetics of niacin and its metabolites.
J Clin Pharmacol
; 47(6): 681-8, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17463214
20.
Safety and Efficacy of Intravenous Golimumab in Patients With Active Psoriatic Arthritis: Results Through Week Twenty-Four of the GO-VIBRANT Study.
Arthritis Rheumatol
; 69(11): 2151-2161, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28805045